External validation of the 4C Mortality Score for hospitalised patients with COVID-19 in the RECOVER network.

Alexandra June GordonPrasanthi GovindarajanChristopher L BennettLoretta MathesonMichael A KohnCarlos CamargoJeffrey A Kline

Published in: BMJ open (2022)

We independently validated 4C Score as predicting risk of 30-day mortality in hospitalised SARS-CoV-2+ patients. We recommend dropping the CRP component of the score and using our recalibrated mortality risk estimates.

Keyphrases

sars cov
end stage renal disease
cardiovascular events
newly diagnosed
chronic kidney disease
risk factors
peritoneal dialysis
prognostic factors
cardiovascular disease
type diabetes
community acquired pneumonia
coronary artery disease
patient reported
clinical evaluation